Gene · 7014
Papers3,508
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,508
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The regulations of telomerase reverse transcriptase (TERT) in cancer. | Cell Death Dis | 2024 | 38278800 | PubTator, text mining | PubMed |
| A novel AML1-ETO/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemia. | Exp Hematol Oncol | 2024 | 38268050 | PubTator, text mining | PubMed |
| ZNF217: An Oncogenic Transcription Factor and Potential Therapeutic Target for Multiple Human Cancers. | Cancer Manag Res | 2024 | 38259608 | PubTator, text mining | PubMed |
| Unwrap RAP1's Mystery at Kinetoplastid Telomeres. | Biomolecules | 2024 | 38254667 | PubTator, text mining | PubMed |
| Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases. | Redox Biol | 2024 | 38232457 | PubTator, text mining | PubMed |
| A Nested PCR Telomere Fusion Assay Highlights the Widespread End-Capping Protection of Arabidopsis CTC1. | Int J Mol Sci | 2024 | 38203842 | PubTator, text mining | PubMed |
| Paeonol Attenuates Atherosclerosis by Inhibiting Vascular Smooth Muscle Cells Senescence via SIRT1/P53/TRF2 Signaling Pathway. | Molecules | 2024 | 38202844 | PubTator, text mining | PubMed |
| Vemurafenib induces senescence in acute myeloid leukemia and myelodysplastic syndrome by activating the HIPPO signaling pathway: implications for potential targeted therapy. | Biol Direct | 2024 | 38178263 | PubTator, text mining | PubMed |
| The shelterin component TRF2 mediates columnar stacking of human telomeric chromatin. | EMBO J | 2024 | 38177309 | PubTator, text mining | PubMed |
| The ALT pathway generates telomere fusions that can be detected in the blood of cancer patients. | Nat Commun | 2024 | 38167290 | PubTator, text mining | PubMed |
| Shelterin dysfunction promotes CD4+ T cell senescence in Behçet's disease. | Rheumatology (Oxford) | 2024 | 38145496 | PubTator, text mining | PubMed |
| Effects of the Nonstructural Protein-Nucleolar and Coiled-Body Phosphoprotein 1 Protein Interaction on rRNA Synthesis Through Telomeric Repeat-Binding Factor 2 Regulation Under Nucleolar Stress. | AIDS Res Hum Retroviruses | 2024 | 38062753 | PubTator, text mining | PubMed |
| Telomeres cooperate with the nuclear envelope to maintain genome stability. | Bioessays | 2024 | 38047499 | PubTator, text mining | PubMed |
| Long noncoding RNAs as versatile molecular regulators of cellular stress response and homeostasis. | Hum Genet | 2024 | 37782337 | PubTator, text mining | PubMed |
| High-accuracy prediction of colorectal cancer chemotherapy efficacy using machine learning applied to gene expression data. | Front Physiol | 2023 | 38304289 | PubTator, text mining | PubMed |
| Telomere dynamics in human pluripotent stem cells. | Cell Cycle | 2023 | 38219218 | PubTator, text mining | PubMed |
| G-Quadruplexes in Human Telomere: Structures, Properties, and Applications. | Molecules | 2023 | 38202757 | PubTator, text mining | PubMed |
| The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target? | Cells | 2023 | 38201248 | PubTator, text mining | PubMed |
Commentary: Case report: Hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis (POIKTMP) presenting with liver cirrhosis and steroid-responsive interstitial pneumonia. | Front Genet | 2023 | 38188503 | PubTator, text mining | PubMed |
| Nutritional Modulation of Hepcidin in the Treatment of Various Anemic States. | Nutrients | 2023 | 38140340 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7014/papers?page=8